TELA Bio TELA
NASDAQ TELA
$0.64 -0.01 (-1.06%)
At close: Aug 20, 2026 · 1:14 PM UTC

TELA Bio (TELA) Asset Writedowns and Impairment (2018 - 2026)

TELA Bio (TELA) posted quarterly Asset Writedowns and Impairment of $935000.0 for Q1 2026, up 48.41% year-over-year from $630000.0 in Q1 2025, and up 14.3% quarter-over-quarter from $818000.0 in Q4 2025.

TELA Bio (TELA) Asset Writedowns and Impairment (2018 - 2026) Analysis & Trends

TELA Bio's Asset Writedowns and Impairment history runs 9 years deep, the most recent figure standing at $935000.0 for Q1 2026.

  • In Q1 2026, Asset Writedowns and Impairment rose 48.41% year-over-year to $935000.0; the TTM figure through Mar 2026 stood at $2.7 million (down 11.9% YoY), while the FY2025 annual figure was $2.4 million, down 20.14% from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 stood at $935000.0, up from $818000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $1.4 million in Q4 2024, with the low at $57000.0 in Q4 2022.
  • The 5-year median for Asset Writedowns and Impairment is $576000.0 (2023), against an average of $560588.2.
  • Peak annual rise in Asset Writedowns and Impairment reached 640.35% in 2023, while the deepest fall reached 63.22% in 2023.
  • TELA Bio's Asset Writedowns and Impairment stood at $57000.0 in 2022, then jumped by 640.35% to $422000.0 in 2023, then jumped by 229.86% to $1.4 million in 2024, then slumped by 41.24% to $818000.0 in 2025, then increased by 14.3% to $935000.0 in 2026.
  • Business Quant data shows TELA's Asset Writedowns and Impairment at $935000.0 in Q1 2026, $818000.0 in Q4 2025, and $632000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn
10 TELA Bio 36.75 Mn 6.32 Mn 13.94 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 298,000.00
Jun 30, 2026 298,000.00
Mar 31, 2026 935,000.00
Mar 31, 2026 935,000.00
Dec 31, 2025 818,000.00
Dec 31, 2025 818,000.00
Sep 30, 2025 632,000.00
Sep 30, 2025 632,000.00
Jun 30, 2025 280,000.00
Jun 30, 2025 280,000.00
Mar 31, 2025 630,000.00
Mar 31, 2025 630,000.00
Dec 31, 2024 1.39 Mn
Dec 31, 2024 1.39 Mn
Sep 30, 2024 655,000.00
Sep 30, 2024 655,000.00
Jun 30, 2024 348,000.00
Jun 30, 2024 348,000.00
Mar 31, 2024 560,000.00
Mar 31, 2024 560,000.00